September 20, 201109:00-12:10 AM

Chairman:  HuiliangBaiChairman of China Nonprescription Medicines Association (CNMA)

Frances Richmond Director of School of Pharmacy, University of Southern California

Time

Topicof the Speech

Speaker

Title

09:00-09:30

Opening Ceremony

9:30-10:20

TBD

Mingde Yu

Chairman of China Pharmaceutical Enterprises Association(CPEA)

10:20-10:30

Tea Break

10:30-11:20

Globalization trend on R&D of bio-pharm industry

VP of a multinational corporation

11:20-12:10

Updates of FDA policies

Frances Richmond

Director of School of Pharmacy, University of Southern California

September 20, 201113:30-17:50 PM

Theme：International Cooperation among Bio-PharmEnterprises

Chairman:Guoliang YuPresident and CEO of Epitomics Co., Ltd

Gang JinSenior VP of Shanghai Biochip Co., Ltd

Time

Topicof the Speech

Speaker

Title

13:30-14:00

Strategy involvement on China market of multination bio-pharmaceutical companies

VP of multinational corporation

14:00-14:30

Reuglatory Submissions for Biologics                                                                             

Neal Storm

Senior Manager of AmgenCo., Ltd

14:30-15:00

Research strategy from an internationalized perspective: Innovative projects brought back by overseas returnees

Guoliang Yu

President and CEO of EpitomicsCo., Ltd

15:00-15:20

Tea Break

15:20-15:50

Difficulties and strategies on preparation export of domestic pharmaceutical enterprises

Biao Wang

Vice General Manager of HuahaiPharmaceutical Co., LTD

15:50-16:20

Global partners of molecular diagnosis and personalized therapy

Jason Jin

Senior VP of Shanghai Biochip Co., Ltd

16:20-16:50

Analysis on recent investment and financing hotspot in bio-pharm industry

TBD

16:50-17:50

Panel discussion:

How to improve depth and breadth of China International Cooperation among Bio-PharmEnterprises?

September 21, 2011  09:00-12:10 AM

Theme：Cooperation and Development of Bio-pharm CRO/CMO

Chairman: Hancheng ZhangVice President of Shanghai ChemPartner Co. Ltd

TBD

Time

Topicof the Speech

Speaker

Title

09:00-9:30

Development trend of CRO and opportunities for Chinese enterprises

TBD

09:30-10:00

Multi-Regional Clinical Trials (MRCT)and their challenges/associated considerations

Hesham Abdullah

Supervision of Cancer treatment of AmgenCo., Ltd

10:00-10:30

How to make use of CRO resource for domestic pharmaceutical enterprises

VP of Shanghai ChemPartner Co. Ltd

10:30-10:40

Tea Break

10:40-11:10

Tailored service for bio-pharm companies provided by CRO companies

TBD

11:10-11:40

Change of MAH system and prospect on CRO potentials

Bo Wang

CEO of Beijing Qinmai Pharmaceutical, ltd

11:40-12:10

Operation and development of CMO

Lixin Yu

Directorof Beijing LavianaPharmatech Co., Ltd

September 21, 201113:30-18:00 PM

Theme：Development of Innovative Preparation Industry

Forum Chairman

Xingguo MeiDirector of Pharmacy Department, Academy of Military Medical Science

Hak-Kim ChanProfessor in Pharmaceutics, Faculty of Pharmacy, University of Sydney

Time

Topicof the Speech

Speaker

Title

13:30-14:00

Development phase and trend of global innovative preparation

Hak-Kim Chan

Professor in Pharmaceutics, Faculty of Pharmacy, University of Sydney

14:00-14:30

Analysis on establishment and registration of new drug R&D projects

Lurong Cheng

Specialist of Center for Drug Evaluation, SFDA

14:30-15:00

Development of Chinese traditional medicine in new era

Ming Yang

Modern Chinese Traditional medicine preparation, director of the key laboratory

15:00-15:30

Comments on industrialization of nano-liposomes technology

Weiping Yu

Senior Director of American Celsion Corporation

15:30-15:40

Tea Break

15:40-16:10

Discussion on techniques of industrialization of preparation manufacturing

Xingguo Mei

Director of Pharmacy Department, Academy of Military Medical Science

16:10-16:40

How to make use of information and risk control during new drug R&D

TianxiDiao

Researcher of Academy of Military Medical Science

16:40-17:10

Practice on medical technology transferring and commercialization

Jingshan Hu

Merck & Co Inc.

17:10-18:00

Panel discussion:

How to realize the benign interaction between preparations innovation and commercial?